Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
13.51
+0.85 (6.71%)
Oct 21, 2026, 4:00 PM EDT - Market closed
Burning Rock Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 500.64 | 539.57 | 515.82 | 537.44 | 563.24 | 507.86 | |
Revenue Growth | -6.65% | 4.60% | -4.02% | -4.58% | 10.90% | 18.13% |
Cost of Revenue | 127.41 | 136.65 | 153.42 | 174.21 | 183.2 | 143.72 |
Gross Profit | 373.23 | 402.91 | 362.4 | 363.23 | 380.04 | 364.15 |
Selling, General & Admin | 303.12 | 291.27 | 452.54 | 685.53 | 938.58 | 793.35 |
Research & Development | 135.12 | 166.49 | 232.29 | 347.02 | 421.87 | 367.86 |
Operating Expenses | 438.25 | 457.76 | 684.83 | 1,033 | 1,360 | 1,161 |
Operating Income | -65.02 | -54.85 | -322.43 | -669.32 | -980.41 | -797.06 |
Interest Expense | -0.06 | -0.03 | - | - | - | -1.54 |
Interest & Investment Income | 5.88 | 8.05 | 12.21 | 17.96 | 9.36 | 3.46 |
Currency Exchange Gain (Loss) | -7.32 | -6.71 | -0.1 | -0.42 | 1.55 | -0.85 |
Other Non Operating Income (Expenses) | 0.1 | -0.26 | 4.71 | 0.48 | 0.25 | 0.2 |
EBT Excluding Unusual Items | -66.42 | -53.79 | -305.61 | -651.3 | -969.25 | -795.8 |
Asset Writedown | - | - | -35.13 | - | - | - |
Pretax Income | -66.42 | -53.79 | -340.74 | -651.3 | -969.25 | -795.8 |
Income Tax Expense | 1.61 | 1.56 | 5.89 | 2.39 | 1.99 | 0.9 |
Net Income | -68.03 | -55.35 | -346.63 | -653.69 | -971.23 | -796.7 |
Net Income to Common | -68.03 | -55.35 | -346.63 | -653.69 | -971.23 | -796.7 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 11 | 11 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 11 | 11 | 10 | 10 | 10 | 10 |
Shares Change | 0.43% | 3.27% | 0.53% | -1.46% | -0.29% | 51.83% |
EPS (Basic) | -6.42 | -5.21 | -33.67 | -63.84 | -93.47 | -76.45 |
EPS (Diluted) | -6.42 | -5.21 | -33.67 | -63.84 | -93.47 | -76.45 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -17.47 | -33.69 | -97.68 | -263.89 | -527.1 | -688.81 |
Free Cash Flow Per Share | -1.65 | -3.17 | -9.49 | -25.77 | -50.73 | -66.10 |
Gross Margin | 74.55% | 74.67% | 70.26% | 67.58% | 67.47% | 71.70% |
Operating Margin | -12.99% | -10.17% | -62.51% | -124.54% | -174.07% | -156.94% |
Profit Margin | -13.59% | -10.26% | -67.20% | -121.63% | -172.44% | -156.87% |
Free Cash Flow Margin | -3.49% | -6.24% | -18.94% | -49.10% | -93.58% | -135.63% |
EBITDA | -58.27 | -33.22 | -271.05 | -537.87 | -859.66 | -752.46 |
EBITDA Margin | -11.64% | -6.16% | -52.55% | -100.08% | -152.63% | -148.16% |
D&A For EBITDA | 6.74 | 21.62 | 51.39 | 131.45 | 120.75 | 44.6 |
EBIT | -65.02 | -54.85 | -322.43 | -669.32 | -980.41 | -797.06 |
EBIT Margin | -12.99% | -10.17% | -62.51% | -124.54% | -174.07% | -156.94% |
Revenue as Reported | 539.57 | 539.57 | 515.82 | 537.44 | 563.24 | 507.86 |